Nothing puts time into perspective like a cancer diagnosis.
At Ellis Fischel Cancer Center, we’re moving cancer care forward. Because we know each breakthrough gives our patients more time for the moments that matter most. It’s a momentum we carry not only in our research, but in everything we do – from the design of our facility to our highly specialized teams.
Being part of an academic health system allows us be at the forefront of the next medical breakthrough. And with each new discovery, we’re able to give our patients the comfort of knowing they’re getting the advanced care they need, with the best care possible.
Tom was told he had nine months. It's been 20 years.
Diagnosed with a grade 4 brain tumor, Tom and his team at Ellis Fischel used the hope of "one day more" to move cancer care forward. Watch his story below.
The Ellis Fischel Difference
With access to the latest technologies, research, clinical trials and treatment, our doctors and staff work hard to make sure each patient receives the safest, most effective care for their cancer diagnosis. We work in collaborative teams, with specialists from different areas coming together, to not only coordinate care, but to ensure it’s as personalized and streamlined as possible.
We’re at the forefront of cancer care at Ellis Fischel. Not only do our patients have access to lifesaving clinical trials, our doctors are training the next generation of specialists to take treatments and cures even further. Learn more.
Our team approach to helping patients overcome cancer brings together a variety of experts to provide coordinated care at every step – from understanding each phase of treatment to housing family members nearby. Learn more.
Just like DNA, every person’s cancer journey is different. And that’s why Ellis Fischel offers tailored treatments for our patients based on their own genetics. Learn more.
How Ellis Fischel is Moving Cancer Care Forward
From our expert and empathetic care to our team approach and commitment to cancer research, we’re here to help patients and families overcome cancer. See how each day, Ellis Fischel provides new treatments and groundbreaking research to move cancer care forward.
How Far We’ve Come
We’re proud of our history and how far we’ve come to provide our patients with the most advanced cancer care. But we’re not done. Thanks to precision medicine and the upcoming opening of our NextGen Precision Health Institute, our doctors and researchers will continue their leading-edge research looking at each patient’s genetics, lifestyle and environment to offer the most effective treatment options and cures.
• Ellis Fischel milestones • Cancer treatment and technology • Cancer care milestones
with latest cancer treatment (surgery, radiation and X-ray), a floor dedicated to clinical research labs and the Midwest’s largest supply of radium (few hospitals met the strict standards for stocking radium)
for radiation therapy
using chemotherapy (pediatric leukemia)
drug, nitrogen mustard
(choriocarcinoma) using chemotherapy
leads to partial and complete remission (acute leukemia)
hospitals to test various chemo drugs
(Clinac-6) is introduced
and linked to 95 percent of patients with chronic myelogenous leukemia
Epstein-Barr virus (EBL)
(MOPP – advanced Hodgkin lymphoma)
for research and clinical applications
implanted in prostate (brachytherapy) shown to extend lives versus surgical removal of prostate
as more limited procedure and becomes available at Ellis Fischel
with expanded lab space and new OR suite
one of only four in the U.S
chemo after surgery, has success with early breast cancer, sets stage for others
the most commonly mutated gene in cancer
to prevent cancer-causing hepatitis B and becomes available at Ellis Fischel
for breast cancer
shows similar survival rates versus mastectomy alone for women with early-stage breast cancer
(prostate-specific antigen) test to screen for prostate cancer and becomes available at Ellis Fischel
first commercial radiopharmaceutical to fight cancer
(Bacillus Calmette-Guerin cancer vaccine)
in Tamoxifen clinical trial for breast cancer prevention
and linked to increased risk of breast cancer
and linked to increased risk of breast cancer
Quadramet, to relieve pain caused by bone cancer
rituximab; first antibody treatment
helps certain women reduce risk of breast cancer by 90 percent
to target tumors close to the organs
chemo before surgery, clinical trial helps women undergo lumpectomy instead of full mastectomy
for breast cancer prevention, thanks in part to Ellis Fischel clinical trials
to carry radiation to the liver
from NCI to establish premier center for developing radiopharmaceuticals
bevacizumab, to block growth of blood vessels tumors need to grow
vaccination against HPV and becomes available at Ellis Fischel
the second vaccination of HPV and becomes available at Ellis Fischel
that uses a patient’s own immune system and becomes available at Ellis Fischel
to screen for breast cancer
Frederick Hawthorne, PhD, receives award for developing boron neutron capture therapy for cancer patients
chimeric antigen receptor modified T-cell (CAR-T) causes complete remission for majority of young patients with acute lymphoblastic leukemia (ALL)
MU School of Medicine researchers discover combining blueberry extract with radiation can increase the treatment’s effectiveness for cervical cancer